Jean-Luc Belingard - 02 Feb 2022 Form 4 Insider Report for LABORATORY CORP OF AMERICA HOLDINGS (LH)

Role
Director
Signature
/s/ Sandra D. van der Vaart, Attorney-in-Fact for Jean-Luc Belingard
Issuer symbol
LH
Transactions as of
02 Feb 2022
Net transactions value
-$21,308
Form type
4
Filing time
04 Feb 2022, 08:00:57 UTC
Next filing
15 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LH Common Stock Options Exercise +771 +5% 16,340 02 Feb 2022 Direct F1
transaction LH Common Stock Tax liability $21,308 -78 -0.48% $273.18 16,262 02 Feb 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LH Restricted Stock Unit Options Exercise $0 -771 -100% $0.000000* 0 02 Feb 2022 Common Stock 771 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2 Stock withholding to satisfy tax withholding obligations.
F3 The Restricted Stock Units vested fully on February 2, 2022.